Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3703
Revised: September 20, 2024
Accepted: October 25, 2024
Published online: December 27, 2024
Processing time: 192 Days and 3 Hours
Near-infrared fluorescence imaging via using intravenous indocyanine green (ICG) has a wide range of applications in multiple surgical scenarios. In lapa
To investigate the novel imaging strategy MCFI in LC.
This was a single-center retrospective study conducted at Peking Union Medical College Hospital, Beijing, China. Patients who underwent LC from June 2022 to March 2023 by the same surgical team were enrolled. Demographic features, clinical and surgical information were collected. The clarity, visual comfort, and effectiveness of different imaging strategies were subjectively evaluated by surgeons.
A total of 155 patients were included, 60 patients were in the non-ICG group in which only bright light illuminance without ICG was applied, 60 patients were in the SCFI group, and 35 patients were in the MCFI group. No statistically significant differences were found in demographics or clinical history. Post-surgical complications were minimal in all 3 groups with no significant differences observed. MCFI improved the clarity of imaging and visual comfort. Clarity of imaging and visual comfort were improved with MCFI.
MCFI improves biliary visualization and reduces liver fluorescence contamination, which supports its routine use in LC. MCFI may also be a better choice than SCFI in other clinical settings.
Core Tip: Near-infrared fluorescence imaging using intravenous indocyanine green facilitates intraoperative identification of biliary anatomy. However, the conventional single color strategy has limited distinguishable differences and the scale range of the fluorescence intensity; and the green fluorescence could cause visual fatigue on a reddish surgical background. Therefore, we aim to develop a novel multi-color fluorescence imaging strategy to correlate the fluorescence intensity. To help alleviate visual fatigue and observe structures with extreme low fluorescence intensity, we utilized a color range of blue to purple, and performed primary clinical trials in a large Chinese gallbladder disease center.